NanoLuc  ||| S:0 E:8 ||| JJ
reporter  ||| S:8 E:17 ||| NN
for  ||| S:17 E:21 ||| IN
dual  ||| S:21 E:26 ||| JJ
luciferase  ||| S:26 E:37 ||| JJ
imaging  ||| S:37 E:45 ||| NN
in  ||| S:45 E:48 ||| IN
living  ||| S:48 E:55 ||| VBG
animals  ||| S:55 E:63 ||| NNS
Bioluminescence  ||| S:63 E:79 ||| JJ
imaging  ||| S:79 E:87 ||| NN
is  ||| S:87 E:90 ||| VBZ
widely  ||| S:90 E:97 ||| RB
used  ||| S:97 E:102 ||| VBN
for  ||| S:102 E:106 ||| IN
cell-based  ||| S:106 E:117 ||| JJ
assays  ||| S:117 E:124 ||| NN
and  ||| S:124 E:128 ||| CC
animal  ||| S:128 E:135 ||| JJ
imaging  ||| S:135 E:143 ||| NN
studies  ||| S:143 E:151 ||| NNS
in  ||| S:151 E:154 ||| IN
biomedical  ||| S:154 E:165 ||| JJ
research  ||| S:165 E:174 ||| NN
and  ||| S:174 E:178 ||| CC
drug  ||| S:178 E:183 ||| NN
development ||| S:183 E:194 ||| NN
,  ||| S:194 E:196 ||| ,
capitalizing  ||| S:196 E:209 ||| VBG
on  ||| S:209 E:212 ||| IN
the  ||| S:212 E:216 ||| DT
high  ||| S:216 E:221 ||| JJ
signal  ||| S:221 E:228 ||| NN
to  ||| S:228 E:231 ||| TO
background  ||| S:231 E:242 ||| NN
of  ||| S:242 E:245 ||| IN
this  ||| S:245 E:250 ||| DT
technique ||| S:250 E:259 ||| NN
.  ||| S:259 E:261 ||| .
A  ||| S:261 E:263 ||| DT
relatively  ||| S:263 E:274 ||| RB
small  ||| S:274 E:280 ||| JJ
number  ||| S:280 E:287 ||| NN
of  ||| S:287 E:290 ||| IN
luciferases  ||| S:290 E:302 ||| NNS
are  ||| S:302 E:306 ||| VBP
available  ||| S:306 E:316 ||| JJ
for  ||| S:316 E:320 ||| IN
imaging  ||| S:320 E:328 ||| JJ
studies ||| S:328 E:335 ||| NNS
,  ||| S:335 E:337 ||| ,
substantially  ||| S:337 E:351 ||| RB
limiting  ||| S:351 E:360 ||| VBG
the  ||| S:360 E:364 ||| DT
ability  ||| S:364 E:372 ||| NN
to  ||| S:372 E:375 ||| TO
image  ||| S:375 E:381 ||| VB
multiple  ||| S:381 E:390 ||| JJ
molecular  ||| S:390 E:400 ||| NN
and  ||| S:400 E:404 ||| CC
cellular  ||| S:404 E:413 ||| JJ
events ||| S:413 E:419 ||| NNS
,  ||| S:419 E:421 ||| ,
as  ||| S:421 E:424 ||| RB
done  ||| S:424 E:429 ||| VBN
commonly  ||| S:429 E:438 ||| RB
with  ||| S:438 E:443 ||| IN
fluorescence  ||| S:443 E:456 ||| JJ
imaging ||| S:456 E:463 ||| NN
.  ||| S:463 E:465 ||| .
To  ||| S:465 E:468 ||| TO
advance  ||| S:468 E:476 ||| VB
dual  ||| S:476 E:481 ||| JJ
reporter  ||| S:481 E:490 ||| NN
bioluminescence  ||| S:490 E:506 ||| VBZ
molecular  ||| S:506 E:516 ||| JJ
imaging ||| S:516 E:523 ||| NN
,  ||| S:523 E:525 ||| ,
we  ||| S:525 E:528 ||| PRP
tested  ||| S:528 E:535 ||| VBD
a  ||| S:535 E:537 ||| DT
recently  ||| S:537 E:546 ||| RB
developed ||| S:546 E:555 ||| VBN
,  ||| S:555 E:557 ||| ,
adenosine  ||| S:557 E:567 ||| FW
triphosphate–independent  ||| S:567 E:592 ||| FW
luciferase  ||| S:592 E:603 ||| FW
enzyme  ||| S:603 E:610 ||| FW
from  ||| S:610 E:615 ||| FW
Oplophorus  ||| S:615 E:626 ||| FW
gracilirostris  ||| S:626 E:641 ||| FW
( ||| S:641 E:642 ||| -LRB-
NanoLuc  ||| S:642 E:650 ||| NNP
[ ||| S:650 E:651 ||| -LRB-
NL ||| S:651 E:653 ||| NNP
] ||| S:653 E:654 ||| -RRB-
)  ||| S:654 E:656 ||| -RRB-
as  ||| S:656 E:659 ||| IN
a  ||| S:659 E:661 ||| DT
reporter  ||| S:661 E:670 ||| NN
for  ||| S:670 E:674 ||| IN
animal  ||| S:674 E:681 ||| JJ
imaging ||| S:681 E:688 ||| NN
.  ||| S:688 E:690 ||| .
We  ||| S:690 E:693 ||| PRP
demonstrated  ||| S:693 E:706 ||| VBD
that  ||| S:706 E:711 ||| IN
NL  ||| S:711 E:714 ||| NNP
could  ||| S:714 E:720 ||| MD
be  ||| S:720 E:723 ||| VB
imaged  ||| S:723 E:730 ||| VBN
in  ||| S:730 E:733 ||| IN
superficial  ||| S:733 E:745 ||| JJ
and  ||| S:745 E:749 ||| CC
deep  ||| S:749 E:754 ||| JJ
tissues  ||| S:754 E:762 ||| NNS
in  ||| S:762 E:765 ||| IN
living  ||| S:765 E:772 ||| VBG
mice ||| S:772 E:776 ||| NNS
,  ||| S:776 E:778 ||| ,
although  ||| S:778 E:787 ||| IN
the  ||| S:787 E:791 ||| DT
detection  ||| S:791 E:801 ||| NN
of  ||| S:801 E:804 ||| IN
NL  ||| S:804 E:807 ||| NNP
in  ||| S:807 E:810 ||| IN
deep  ||| S:810 E:815 ||| JJ
tissues  ||| S:815 E:823 ||| NNS
was  ||| S:823 E:827 ||| VBD
limited  ||| S:827 E:835 ||| VBN
by  ||| S:835 E:838 ||| IN
emission  ||| S:838 E:847 ||| NN
of  ||| S:847 E:850 ||| IN
predominantly  ||| S:850 E:864 ||| RB
blue  ||| S:864 E:869 ||| JJ
light  ||| S:869 E:875 ||| NN
by  ||| S:875 E:878 ||| IN
this  ||| S:878 E:883 ||| DT
enzyme ||| S:883 E:889 ||| NN
.  ||| S:889 E:891 ||| .
Changes  ||| S:891 E:899 ||| NNS
in  ||| S:899 E:902 ||| IN
bioluminescence  ||| S:902 E:918 ||| NN
from  ||| S:918 E:923 ||| IN
NL  ||| S:923 E:926 ||| NNP
over  ||| S:926 E:931 ||| IN
time  ||| S:931 E:936 ||| NN
could  ||| S:936 E:942 ||| MD
be  ||| S:942 E:945 ||| VB
used  ||| S:945 E:950 ||| VBN
to  ||| S:950 E:953 ||| TO
quantify  ||| S:953 E:962 ||| VB
tumor  ||| S:962 E:968 ||| NN
growth ||| S:968 E:974 ||| NN
,  ||| S:974 E:976 ||| ,
and  ||| S:976 E:980 ||| CC
secreted  ||| S:980 E:989 ||| JJ
NL  ||| S:989 E:992 ||| NNP
was  ||| S:992 E:996 ||| VBD
detectable  ||| S:996 E:1007 ||| VBN
in  ||| S:1007 E:1010 ||| IN
small  ||| S:1010 E:1016 ||| JJ
volumes  ||| S:1016 E:1024 ||| NNS
of  ||| S:1024 E:1027 ||| IN
serum ||| S:1027 E:1032 ||| NN
.  ||| S:1032 E:1034 ||| .
We  ||| S:1034 E:1037 ||| PRP
combined  ||| S:1037 E:1046 ||| VBD
NL  ||| S:1046 E:1049 ||| NNP
and  ||| S:1049 E:1053 ||| CC
firefly  ||| S:1053 E:1061 ||| JJ
luciferase  ||| S:1061 E:1072 ||| JJ
reporters  ||| S:1072 E:1082 ||| NNS
to  ||| S:1082 E:1085 ||| TO
quantify  ||| S:1085 E:1094 ||| VB
two  ||| S:1094 E:1098 ||| CD
key  ||| S:1098 E:1102 ||| JJ
steps  ||| S:1102 E:1108 ||| NNS
in  ||| S:1108 E:1111 ||| IN
transforming  ||| S:1111 E:1124 ||| VBG
growth  ||| S:1124 E:1131 ||| NN
factor  ||| S:1131 E:1138 ||| NN
β  ||| S:1138 E:1140 ||| VBZ
signaling  ||| S:1140 E:1150 ||| VBG
in  ||| S:1150 E:1153 ||| IN
intact  ||| S:1153 E:1160 ||| JJ
cells  ||| S:1160 E:1166 ||| NNS
and  ||| S:1166 E:1170 ||| CC
living  ||| S:1170 E:1177 ||| VBG
mice ||| S:1177 E:1181 ||| NNS
,  ||| S:1181 E:1183 ||| ,
establishing  ||| S:1183 E:1196 ||| VBG
a  ||| S:1196 E:1198 ||| DT
novel  ||| S:1198 E:1204 ||| NN
dual  ||| S:1204 E:1209 ||| JJ
luciferase  ||| S:1209 E:1220 ||| JJ
imaging  ||| S:1220 E:1228 ||| NN
strategy  ||| S:1228 E:1237 ||| NN
for  ||| S:1237 E:1241 ||| IN
quantifying  ||| S:1241 E:1253 ||| JJ
signal  ||| S:1253 E:1260 ||| NN
transduction  ||| S:1260 E:1273 ||| NNS
and  ||| S:1273 E:1277 ||| CC
drug  ||| S:1277 E:1282 ||| NN
targeting ||| S:1282 E:1291 ||| VBG
.  ||| S:1291 E:1293 ||| .
Our  ||| S:1293 E:1297 ||| PRP$
results  ||| S:1297 E:1305 ||| NNS
establish  ||| S:1305 E:1315 ||| VB
NL  ||| S:1315 E:1318 ||| NNP
as  ||| S:1318 E:1321 ||| IN
a  ||| S:1321 E:1323 ||| DT
new  ||| S:1323 E:1327 ||| JJ
reporter  ||| S:1327 E:1336 ||| NN
for  ||| S:1336 E:1340 ||| IN
bioluminescence  ||| S:1340 E:1356 ||| JJ
imaging  ||| S:1356 E:1364 ||| NN
studies  ||| S:1364 E:1372 ||| NNS
in  ||| S:1372 E:1375 ||| IN
intact  ||| S:1375 E:1382 ||| JJ
cells  ||| S:1382 E:1388 ||| NNS
and  ||| S:1388 E:1392 ||| CC
living  ||| S:1392 E:1399 ||| VBG
mice  ||| S:1399 E:1404 ||| NNS
that  ||| S:1404 E:1409 ||| WDT
will  ||| S:1409 E:1414 ||| MD
expand  ||| S:1414 E:1421 ||| VB
imaging  ||| S:1421 E:1429 ||| VBN
of  ||| S:1429 E:1432 ||| IN
signal  ||| S:1432 E:1439 ||| NN
transduction  ||| S:1439 E:1452 ||| NN
in  ||| S:1452 E:1455 ||| IN
normal  ||| S:1455 E:1462 ||| JJ
physiology ||| S:1462 E:1472 ||| NN
,  ||| S:1472 E:1474 ||| ,
disease ||| S:1474 E:1481 ||| NN
,  ||| S:1481 E:1483 ||| ,
and  ||| S:1483 E:1487 ||| CC
drug  ||| S:1487 E:1492 ||| NN
development ||| S:1492 E:1503 ||| NN
.  ||| S:1503 E:1505 ||| .
